Across TCGA pan-cancer cohorts, IFITM9P RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of IFITM9P’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where IFITM9P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types IFITM9P is over-expressed in tumor, although a few such as KICH and THCA show the opposite, repressed pattern.
COAD, KIRC, and HNSC are the cancer types where IFITM9P tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in IFITM9P RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.